EcoDrugPlus

Ensembl ID : ENSUAMG00000021831
Gene Symbol: -
Cross references: -
430 Possible Orthologues:

Ensembl ID : ENSUAMG00000021717
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSUAMG00000021543
Gene Symbol: -
Cross references: -
331 Possible Orthologues:

Ensembl ID : ENSUAMG00000021530
Gene Symbol: -
Cross references: -
273 Possible Orthologues:

Ensembl ID : ENSUAMG00000021529
Gene Symbol: -
Cross references: -
273 Possible Orthologues:

Ensembl ID : ENSUAMG00000021353
Gene Symbol: -
Cross references: -
269 Possible Orthologues:

Ensembl ID : ENSUAMG00000021225
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSUAMG00000003725
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSUAMG00000020638
Gene Symbol: -
Cross references: -
64 Possible Orthologues:

Ensembl ID : ENSUAMG00000019201
Gene Symbol: -
Cross references: -
132 Possible Orthologues:

Ensembl ID : ENSUAMG00000000812
Gene Symbol: -
Cross references: -
280 Possible Orthologues:

Ensembl ID : ENSUAMG00000018794
Gene Symbol: -
Cross references: -
154 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).